Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2019

Dec 17, 2019

29995_dirs_2019-12-17_58643d08-fce8-4ad3-816d-7f300eb8fc5c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2019-12-13

Reporting Person: HUBBARD ROBERT GLENN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-13 Common Stock A 442 $50.38 Acquired 58850 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-13 Deferred Share Equivalents $ A 212 Acquired Common Stock (212.0) Direct
2019-12-16 Deferred Share Equivalents $ J 24485 Disposed Common Stock (24485.0) Direct

Footnotes

F1: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F4: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.